Try our Advanced Search for more refined results
July 01, 2015
ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company et al
Case Number:
2:15-cv-01202
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 28, 2017
Lilly Loses Bid To Escape $20M Cialis Patent Verdict
Eli Lilly & Co. on Friday lost a post-trial attempt to invalidate a German pharmaceutical company's patent when a Texas federal court denied a motion for judgment or a new trial, leaving Lilly to pay $20 million for infringing the patent when marketing the erectile dysfunction drug Cialis to treat enlarged prostates.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login